Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 30, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - May 30, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 25     Go To Page:

5/29/17 - Mental Disorders - a Neglected Challenge [analysis]
AT Independence, in 1961, Tanzania did not have a single mental case associated with narcotic drug abuse. The drugs problem cropped up around 1970 when the Police Department registered a sharp increase in petty offences. Today, Dodoma Regional hospital receives an average ranging between 15 to 20 patients a week suffering from mental breakdown.
5/29/17 - Patent Application Titled "Device and Method for Controlling the Release of Bioactive and Therapeutic Agents from an Implantable Medical Device"...
Patent Application Titled "Device and Method for Controlling the Release of Bioactive and Therapeutic Agents from an Implantable Medical Device" Published Online. By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors
5/29/17 - Researchers Submit Patent Application, "Method for Improving Health Outcomes", for Approval (USPTO 20170128600)
By a News Reporter-Staff News Editor at Pharma Business Week From Washington, D.C., NewsRx journalists report that a patent application by the inventor WOODY, Stephen T., filed on June 20, 2016, was made available online on May 18, 2017. The patent's assignee is Avadim Technologies, Inc.. In spite of these developments in sanitizing cleansers, th
5/27/17 - Attorney General Becerra Announces $33M Nationwide Settlement After Maker of Tylenol, Motrin, Benadryl Produced Adulterated Medicine
California Attorney General Xavier Becerra issued the following news release:. California Attorney General Xavier Becerra announced a $33 million settlement with drug manufacturer Johnson& Johnson after it violated federal regulations between 2009 and 2011 that ensure the quality of certain medicines, including many consumed by children.
5/27/17 - Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC) [Sport360]
-In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival was 16.6 months, compared to 8.1 months with chemotherapy. Basel, May 26, 2017- Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia to include the first-line treatment of patients with metastatic non-small cell lung can
5/26/17 - GNW-News: Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC) (english)
Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer. Novartis International AG/ Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer. Basel, May 26, 2017- Novartis today announced the US Food and Drug.
5/26/17 - Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)
Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia to include the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors are anaplastic lymphoma kinase- positive, as detected by an FDA- approved test. In January 2017, the FDA granted Zykadia Breakthrough Therapy..
5/26/17 - Schuette Urges Legislature to Use $859,000 Settlement for Opioid Education, Addiction Prevention Programs
Michigan Attorney General Bill Schuette issued the following news release:. Michigan Attorney General Bill Schuette today urged the Michigan Legislature to direct $859,120 in proceeds Michigan will receive as part of a $33 million dollar national settlement his office helped negotiate with a pharmaceutical company towards opioid addiction education
5/26/17 - SeeThruEquity Issues Update on Innovus Pharmaceuticals (INNV) with Price Target of $0.65
NEW YORK, NY/ ACCESSWIRE/ May 26, 2017/ SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Innovus Pharmaceuticals, Inc.. Innovus Pharmaceuticals, Inc. is a fast-growing commercial stage pharmaceutical company that delivers sa
5/25/17 - AG Paxton, 42 States Reach $33 Million Settlement with Johnson & Johnson Regarding Quality of Over-Counter Drugs
Attorney General Ken Paxton today announced that Texas will receive more than $2.2 million in a $33 million, 43- state settlement with pharmaceutical company Johnson& Johnson. From 2009 to 2011, alleged quality control lapses by McNeil-PPC, Inc., a wholly-owned subsidiary of Johnson& Johnson, resulted in recalls of many over-the-counter drugs for a
5/25/17 - Hepatitis has been on the rise
Hepatitis has been on the rise in Swain County and other parts of the country. The rise of injection drug use in Swain County and the rest of the United States is linked to the spread of Hepatitis C. In Swain County, there is a high incidence of drug use both prescription and non-prescription drugs, and injection is becoming more common among those
5/25/17 - Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States [Sport360]
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve mens and women`s health and respiratory diseases, today announced the launch of AllerVarx in the U.S. AllerVarx is a clinically proven supplement,...
5/24/17 - Attorney General Madigan, 42 Attorneys General Reach $33 Million Settlement with Johnson & Johnson Over Misrepresentation of Drug Quality
Attorney General Lisa Madigan and 42 other attorneys general today announced they have reached a $33 million settlement with Johnson& Johnson and its subsidiary over misrepresentations it made about manufacturing practices of well-known, over-the-counter drugs that resulted in recalls of products manufactured between 2009 and 2011, including...
5/24/17 - Drugmaker paying $33M over recalled nonprescription meds
Johnson& Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold nonprescription medicines that didn't meet federal quality requirements. The case dates to 2009, when Johnson& Johnson began dozens of voluntary recalls of popular over-the-counter medicines for children and adults, including Ty
5/24/17 - GUEST COLUMN
Driving near Monterey, California, recently, I stopped at a roadside stand to buy some freshly picked strawberries. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug
5/24/17 - HIA Comments on FTC Now Hear This Workshop and OTC Hearing Aids
The Hearing Industries Association (HIA) has issued a position paper in response to what the organization sees as several inaccurate statements made at the recent April 18 FTC Workshop titled, Now Hear This.
5/24/17 - How to lower your Medicare drug costs
Driving near Monterey, California, recently, I stopped at a roadside stand to buy some freshly picked strawberries. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug
5/24/17 - Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced the launch of AllerVarx? in the U.S. AllerVarx? is a clinically proven supplement,..
5/24/17 - Myovant Sciences Announces Presentation of Data at the European Congress of Endocrinology from Phase 2 Extension Study Evaluating Relugolix in Women with Endometriosis-Associated Pain
Myovant Sciences today announced the presentation of data from a Phase 2 extension study conducted by Takeda Pharmaceutical Company Ltd. evaluating relugolix in Japanese women with endometriosis-associated pain. Oral, once-daily treatment with relugolix was generally well tolerated during the 24 weeks comprising the initial 12- week study and the
5/24/17 - Napo Pharmaceuticals New Mytesi Video Calls Attention to the Continuing Widespread Problem of Diarrhea in People Living With HIV/AIDS
Napo Pharmaceuticals, Inc., a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, which launched Mytesi in April, 2017, and Jaguar Animal Health, Inc., an animal health company which has licensed worldwide veterinary rights to Mytesi and is focuse
5/23/17 - DKSH and Boehringer Ingelheim improve access to treatment in Myanmar
DKSH and Boehringer Ingelheim improve access to treatment in Myanmar. DKSH, the leading Market Expansion Services provider with a focus on Asia, and Boehringer Ingelheim, one of the world's top 20 pharmaceutical companies, have signed an agreement to provide Myanmar patients better treatment options in vascular disease, arterial hypertension, cance
5/23/17 - Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks
The Health Care Sector which includes biotech, pharmaceutical and medical device stocks, continues to forge ahead despite recent concerns in the markets as some of the larger companies show attractive earnings growth potential all tied to new drug innovation, FDA approvals and device roll-outs. Health Care and Pharma stocks with developments and ma
5/23/17 - Medicare Q&A: Lower your Medicare drug costs
May is high season for California strawberries, and the fields were exploding with beautiful, ripe fruit. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug coverage m
5/23/17 - Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced a collaboration today with International Security Group to develop its ner
5/23/17 - Sunovion Announces Utibron? Neohaler (indacaterol/glycopyrrolate) Inhalation Powder Data Showing Lung Function and Health-Related Quality of Life Improvement in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sunovion Pharmaceuticals Inc. announced that multiple data analyses from two Phase 3 studies demonstrating that Utibron? Neohaler inhalation powder improved lung function, health-related quality of life, dyspnea and night-time symptoms compared to placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, were...
Articles(s): 1 - 25 of 25     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415